Similar articles

• A multivariate analysis of prognostic factors in disseminated non-seminomatous testicular cancer.

  Stoter G, Sylvester R, Sleijfer DT, ten Bokkel Huinink WW, Kaye SB, Jones WG, van Oosterom AT, Vendrik CP, Spaander P, de Pauw M. Stoter G, et al. Prog Clin Biol Res. 1988;269:381-93. Prog Clin Biol Res. 1988. PMID: 2455909 Clinical Trial. No abstract available.
• Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.

  Raghavan D, Levi J, Thomson D, Harvey V. Raghavan D, et al. Prog Clin Biol Res. 1990;350:319-29. Prog Clin Biol Res. 1990. PMID: 1696742 Review. No abstract available.
• [Chemotherapy of disseminated germ cell tumors of the testis].

  Tiuliandin SA. Tiuliandin SA. Sov Med. 1987;(11):78-81. Sov Med. 1987. PMID: 2451298 Review. Russian. No abstract available.
• Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.

  Brada M, Horwich A, Peckham MJ. Brada M, et al. Cancer Treat Rep. 1987 Jun;71(6):655-6. Cancer Treat Rep. 1987. PMID: 2438041
• Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.

  Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ. Williams SD, et al. N Engl J Med. 1987 Jun 4;316(23):1435-40. doi: 10.1056/NEJM198706043162302. N Engl J Med. 1987. PMID: 2437455 Clinical Trial.